{"text": ["Here's", "Why", "Coherus", "BioSciences", "Rose", "48.7%", "in", "January"], "created_at": "2019-02-11 21:38:16"}
{"text": ["Here's", "Why", "Coherus", "BioSciences", "Rose", "48.7%", "in", "January"], "created_at": "2019-02-11 21:38:16"}
{"text": ["5", "High-Growth", "Stocks", "Undervalued", "by", "the", "Market"], "created_at": "2019-02-11 20:24:13"}
{"text": ["Here&apos;s", "Why", "Coherus", "BioSciences", "Rose", "48.7%", "in", "January"], "created_at": "2019-02-11 19:46:00"}
{"text": ["IWV,", "PEP,", "ABBV,", "AMGN:", "ETF", "Outflow", "Alert"], "created_at": "2019-02-11 17:36:20"}
{"text": ["IWV,", "PEP,", "ABBV,", "AMGN:", "ETF", "Outflow", "Alert"], "created_at": "2019-02-11 17:36:20"}
{"text": ["AbbVie", "and", "Teneobio", "Announce", "a", "Strategic", "Transaction", "to", "Develop", "a", "New", "Treatment", "for", "Multiple", "Myeloma"], "created_at": "2019-02-11 13:00:00"}
{"text": ["ABBV", "or", "CELG:", "Comparing", "Dividends,", "Interest", "Expenses,", "and", "Debt"], "created_at": "2019-02-11 12:31:08"}
